CytomaxGen 1Reproductive System

Prostatilen

Простатилен

🎯

Target Organ

Prostate

Description

Prostatilen is an injectable pharmaceutical peptide bioregulator extracted from prostate tissue. It is the original pharmaceutical form used in Russian clinics for over 30 years. Prostatilen exerts an organotropic (tissue-specific) action on the prostate gland, reducing inflammation, improving microcirculation in prostatic tissue, and normalizing secretory function. It has been extensively studied for chronic prostatitis and benign prostatic hyperplasia (BPH), with clinical trials demonstrating significant improvements in urination, reduction in prostate inflammation, and enhanced sexual function. Prostatilen is available in two forms: intramuscular injection (5-10mg ampules) and rectal suppositories (30-50mg).

⚙️ Mechanism of Action

Organotropic action on the prostate gland, reducing inflammatory cytokines and edema. Improves microcirculation in prostatic capillaries, normalizes secretory epithelium function, and modulates local immune responses.

Primary Benefits

  • ·Reduces prostate inflammation and edema
  • ·Improves urination flow and reduces frequency
  • ·Enhances sexual function and erectile quality
  • ·Supports prostate health and prevents BPH progression

💊Dosing Protocol

Standard Course

5-10mg IM daily for 5-10 days

Intensive Course

OR 50mg rectal suppositories, one daily for 10-15 days; repeat after 1-6 months if needed

🏥Clinical Applications

Chronic prostatitisBPHPost-surgery recoveryMale sexual dysfunction

Scientific Validation

HomeLibraryResearchFavoritesToolsVisuals